HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Study on the gene polymorphismand the levels of α₁-antitrypsin (α1-AT) in patients with lung cancer in Harbin].

AbstractBACKGROUND:
To study the gene polymorphism and the dynamic changes of the level of α₁-antitrypsin(α₁-AT) in patients with lung cancer of Chinese Han race in Harbin and its clinical significance.
METHODS:
The phenotypes of α₁-AT from 99 patients with lung cancer and 749 normal persons were determined by polyacrylamide gel isoelectricfocusing electrophoresis. The levels of α₁-AT in serum were determined by monophonic immunodiffusion.
RESULTS:
The common subtypes, such as M₁M₁ , M₁M₂ , M₂M₃, etc, were positive and the deficiency subtype was negative in both of the two groups. There was no significant difference in phenotypes and gene frequencies between the two groups ( P > 0. 05) . The level of α₁-AT in patients with lung cancer were remarkably higher than that in normal group ( P < 0. 05) , and significantly increased after anti-inflammatory or/and chemical treatment ( P < 0. 05) .
CONCLUSIONS:
There is no significant difference in gene polymorphism of α₁-AT between the patients with lung cancer and normal persons, but the dynamic changes of α₁-AT are valuable to differentiate inflammation from cancer, estimate the efficacy of chemotherapy, and formulate and adjust the treatment scheme.
AuthorsJ Huo, S Yu, H Sun, Y Shi
JournalZhongguo fei ai za zhi = Chinese journal of lung cancer (Zhongguo Fei Ai Za Zhi) Vol. 4 Issue 5 Pg. 327-9 (Oct 20 2001) ISSN: 1009-3419 [Print] China
PMID21059308 (Publication Type: English Abstract, Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: